Moderna Clinical Trials

Find clinical trials for Moderna. Search for Moderna clinical trials in different cities and states across the United States.

e.g. Respiratory Diseases

e.g. Massachusetts•Healthy volunteers: No

Filter results

Results: 10

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

Recruiting

Phase 2

Sponsor:

Moderna

Location:

Boston

Code:

NCT05683457

Conditions

Cytomegalovirus Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mRNA-1647

Placebo

A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Farmington, Boston, Durham, Cincinnatishow 3 more

Code:

NCT05095727

Conditions

Glycogen Storage Disease

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Interventions

mRNA-3745

A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Los Angeles, Palo Alto, Philadelphia

Code:

NCT04899310

Conditions

Methylmalonic Acidemia

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Interventions

mRNA-3705

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

Recruiting

Phase 2

Sponsor:

Moderna

Location:

Tucson, San Francisco, Santa Monica, Aurorashow 11 more

Code:

NCT03897881

Conditions

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mRNA-4157

Pembrolizumab

A Retrospective Study to Characterize Participants With Propionic Acidemia and Methylmalonic Acidemia

Recruiting

Sponsor:

Moderna

Location:

Stanford, Lutherville, Boston, Ann Arborshow 4 more

Code:

NCT05769621

Conditions

Propionic Acidemia

Methylmalonic Acidemia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Los Angeles, Stanford, Baltimore, Bostonshow 6 more

Code:

NCT04159103

Conditions

Propionic Acidemia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

mRNA-3927

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Ann Arbor, Durham, Philadelphia

Code:

NCT05130437

Conditions

Propionic Acidemia

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Interventions

mRNA-3927

An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Los Angeles

Code:

NCT05295433

Conditions

Methylmalonic Acidemia

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Interventions

mRNA-3705

Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors

Recruiting

Phase 1

Sponsor:

Moderna

Location:

Tucson, Washington, Orlando, Sarasotashow 9 more

Code:

NCT03313778

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mRNA-4157

Pembrolizumab

SoC Treatment

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

San Francisco, Aurora, Washington, Orlandoshow 8 more

Code:

NCT05533697

Conditions

Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mRNA-4359

Pembrolizumab

e.g. Respiratory Diseases

e.g. Massachusetts•Healthy volunteers: No

Filter results

Results: 10

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

Recruiting

Phase 2

Sponsor:

Moderna

Location:

Boston

Code:

NCT05683457

Conditions

Cytomegalovirus Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mRNA-1647

Placebo

A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Farmington, Boston, Durham, Cincinnatishow 3 more

Code:

NCT05095727

Conditions

Glycogen Storage Disease

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Interventions

mRNA-3745

A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Los Angeles, Palo Alto, Philadelphia

Code:

NCT04899310

Conditions

Methylmalonic Acidemia

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Interventions

mRNA-3705

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

Recruiting

Phase 2

Sponsor:

Moderna

Location:

Tucson, San Francisco, Santa Monica, Aurorashow 11 more

Code:

NCT03897881

Conditions

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mRNA-4157

Pembrolizumab

A Retrospective Study to Characterize Participants With Propionic Acidemia and Methylmalonic Acidemia

Recruiting

Sponsor:

Moderna

Location:

Stanford, Lutherville, Boston, Ann Arborshow 4 more

Code:

NCT05769621

Conditions

Propionic Acidemia

Methylmalonic Acidemia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Los Angeles, Stanford, Baltimore, Bostonshow 6 more

Code:

NCT04159103

Conditions

Propionic Acidemia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

mRNA-3927

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Ann Arbor, Durham, Philadelphia

Code:

NCT05130437

Conditions

Propionic Acidemia

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Interventions

mRNA-3927

An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Los Angeles

Code:

NCT05295433

Conditions

Methylmalonic Acidemia

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Interventions

mRNA-3705

Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors

Recruiting

Phase 1

Sponsor:

Moderna

Location:

Tucson, Washington, Orlando, Sarasotashow 9 more

Code:

NCT03313778

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mRNA-4157

Pembrolizumab

SoC Treatment

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

San Francisco, Aurora, Washington, Orlandoshow 8 more

Code:

NCT05533697

Conditions

Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mRNA-4359

Pembrolizumab